186 related articles for article (PubMed ID: 342868)
1. [Hepatoxic side-effects of rifampicin. A comparative clinical study].
Kuntz HD; Rausch V
Med Welt; 1977 Nov; 28(47):1940-2. PubMed ID: 342868
[No Abstract] [Full Text] [Related]
2. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
Austerhoff A; Kindler U; Knop P; Knieriem HJ
Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
[No Abstract] [Full Text] [Related]
3. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
Chioléro R
Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
[No Abstract] [Full Text] [Related]
4. [Frequency, diagnosis, and course of hepatotoxic side effects of Rifampicin (author's transl)].
Deck KA; Gehrhardt A; Klein HO; Ludes H
Med Klin; 1976 Oct; 71(43):1836-41. PubMed ID: 995024
[TBL] [Abstract][Full Text] [Related]
5. Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin.
Baron DN; Bell JL
Tubercle; 1974 Jun; 55(2):115-20. PubMed ID: 4620296
[No Abstract] [Full Text] [Related]
6. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
Newman R; Doster B; Murray FJ; Ferebee S
Am Rev Respir Dis; 1971 Apr; 103(4):461-76. PubMed ID: 4994459
[No Abstract] [Full Text] [Related]
7. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
Grönhagen-Riska C; Hellstrom PE; Fröseth B
Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
[TBL] [Abstract][Full Text] [Related]
8. Side effects of rifampicin. A clinical study.
Mattson K
Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
[No Abstract] [Full Text] [Related]
9. [Rifampicin in the treatment of tuberculosis].
Mattson K
Duodecim; 1973; 89(11):807-17. PubMed ID: 4758893
[No Abstract] [Full Text] [Related]
10. Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population.
Neill P; Pringle D; Mhonda M; Kusema T; Nhachi CF
Cent Afr J Med; 1990 Apr; 36(4):104-7. PubMed ID: 2225025
[TBL] [Abstract][Full Text] [Related]
11. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
Newman R; Doster BE; Murray FJ; Woolpert SF
Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
[No Abstract] [Full Text] [Related]
12. Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
Wiman LG; Johansson R; Tegner KB
Scand J Respir Dis; 1973; 54(5):255-63. PubMed ID: 4777378
[No Abstract] [Full Text] [Related]
13. [Hepatoxic effects of rifampicin].
Lechner HJ; Reimers D
Prax Pneumol; 1973 Apr; 27(4):241-9. PubMed ID: 4698443
[No Abstract] [Full Text] [Related]
14. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
15. [Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
Blanchon P; Paillas J; Groseille Y; Holler A; Blanchon F
Ann Med Interne (Paris); 1974 Dec; 125(12):919-22. PubMed ID: 4469954
[No Abstract] [Full Text] [Related]
16. Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis.
Salinger PL; Dormer BA
S Afr Med J; 1972 Mar; 46(13):354-8. PubMed ID: 5074542
[No Abstract] [Full Text] [Related]
17. Hyperlipidaemia as a complication of rifampicin treatment.
Khogali AM; Chazan BI; Metcalf VJ; Ramsay JH
Tubercle; 1974 Sep; 55(3):231-3. PubMed ID: 4470842
[No Abstract] [Full Text] [Related]
18. [Which treatment for primary tuberculosis?].
Gallet S; Bellon G
Pediatrie; 1989; 44(9):699-704. PubMed ID: 2695890
[TBL] [Abstract][Full Text] [Related]
19. Editorial: Rifampin in the treatment of tuberculosis.
Grzybowshi S
Can Med Assoc J; 1974 May; 110(9):1002 passim. PubMed ID: 4823101
[No Abstract] [Full Text] [Related]
20. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
Linna O; Uhari M
Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
